NASDAQ:INGN Inogen (INGN) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free INGN Stock Alerts $6.70 -0.05 (-0.74%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$6.62▼$6.8450-Day Range$6.29▼$10.1552-Week Range$4.13▼$14.10Volume173,383 shsAverage Volume312,529 shsMarket Capitalization$157.79 millionP/E RatioN/ADividend YieldN/APrice Target$7.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Inogen alerts: Email Address Inogen MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside11.9% Upside$7.50 Price TargetShort InterestHealthy7.18% of Shares Sold ShortDividend StrengthN/ASustainability-1.12Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.56) to ($1.96) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.55 out of 5 starsMedical Sector259th out of 910 stocksSurgical Appliances & Supplies Industry9th out of 18 stocks 2.0 Analyst's Opinion Consensus RatingInogen has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageInogen has only been the subject of 2 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted7.18% of the outstanding shares of Inogen have been sold short.Short Interest Ratio / Days to CoverInogen has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inogen has recently decreased by 9.63%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInogen does not currently pay a dividend.Dividend GrowthInogen does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInogen has received a 51.98% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Medical ventilators" product. See details.Environmental SustainabilityThe Environmental Impact score for Inogen is -1.12. Previous Next 2.5 News and Social Media Coverage News SentimentInogen has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.MarketBeat FollowsOnly 1 people have added Inogen to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inogen insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.64% of the stock of Inogen is held by insiders.Percentage Held by Institutions89.94% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Inogen are expected to grow in the coming year, from ($2.56) to ($1.96) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inogen is -1.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inogen is -1.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInogen has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Inogen Stock (NASDAQ:INGN)Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Read More INGN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INGN Stock News HeadlinesApril 16, 2024 | americanbankingnews.comInogen, Inc. (NASDAQ:INGN) Short Interest Down 9.6% in MarchApril 13, 2024 | seekingalpha.comInogen: New Management And A Major Competitor Exit Offer Some New OpportunitiesApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 10, 2024 | businesswire.comInogen to Report First Quarter 2024 Financial Results on May 7, 2024April 9, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)March 25, 2024 | businesswire.comInogen To Present at 23rd Annual Needham Virtual Healthcare ConferenceMarch 18, 2024 | ca.finance.yahoo.comINGN Apr 2024 10.000 callMarch 17, 2024 | finance.yahoo.comINGN Apr 2024 5.000 putApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 17, 2024 | finance.yahoo.comINGN Apr 2024 15.000 callMarch 16, 2024 | finance.yahoo.comINGN Apr 2024 12.500 callMarch 16, 2024 | finance.yahoo.comINGN Apr 2024 7.500 putMarch 13, 2024 | finanznachrichten.deInogen Alliance: Preparing for 4 New EU Environmental Regulations in 2024March 7, 2024 | businesswire.comInogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)March 1, 2024 | finance.yahoo.comInogen Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 29, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | barrons.comInogen Inc.February 28, 2024 | msn.comWhy Is Inogen Stock Plummeting Today?February 27, 2024 | finance.yahoo.comInogen Announces Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 27, 2024 | finance.yahoo.comInogen Inc (INGN) Reports Decline in 2023 Revenue and Widening Net LossFebruary 27, 2024 | businesswire.comInogen Announces Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 27, 2024 | finanznachrichten.deInogen Alliance Ranked #41 in Environment Analyst's Top 100 Global Environmental & Sustainability Consultancy Firms ReportFebruary 26, 2024 | markets.businessinsider.comWhat Wall Street expects from Inogen's earningsFebruary 23, 2024 | benzinga.comInogen Stock (NASDAQ:INGN), Short Interest ReportFebruary 17, 2024 | ca.finance.yahoo.comINGN Mar 2024 10.000 putFebruary 15, 2024 | markets.businessinsider.comCompetitor Exit A Boom For Respiratory Device-Focused Inogen, Earns Analyst UpgradeFebruary 15, 2024 | msn.comInogen stock rallies 22% as William Blair ups rating to outperformSee More Headlines Receive INGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today4/23/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:INGN CUSIPN/A CIK1294133 Webwww.inogen.com Phone(805) 562-0500FaxN/AEmployees834Year Founded2001Price Target and Rating Average Stock Price Target$7.50 High Stock Price Target$8.00 Low Stock Price Target$7.00 Potential Upside/Downside+11.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($4.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-102,450,000.00 Net Margins-32.46% Pretax Margin-32.42% Return on Equity-38.98% Return on Assets-27.03% Debt Debt-to-Equity RatioN/A Current Ratio2.86 Quick Ratio2.55 Sales & Book Value Annual Sales$315.66 million Price / Sales0.50 Cash FlowN/A Price / Cash FlowN/A Book Value$8.79 per share Price / Book0.76Miscellaneous Outstanding Shares23,550,000Free Float23,396,000Market Cap$157.79 million OptionableOptionable Beta1.06 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Jason Somer (Age 56)Executive VP, General Counsel & Corporate Secretary Comp: $409.92kDr. Stanislav Glezer M.D. (Age 51)MBA, Executive VP of R&D and Chief Medical Officer Comp: $575.8kMr. Kevin R. M. Smith (Age 53)President, CEO & Director Mr. Michael J. Bourque (Age 61)Executive VP, CFO & Treasurer Mr. Philip CorrinSenior Vice President of Operations & Supply ChainMs. Jennifer Yi BoyerExecutive VP & Chief Human Resources OfficerMr. Vijay PaliwalSenior Vice President of Enterprise EnablementMr. Grgoire Ramade (Age 54)Executive VP & Chief Commercial Officer More ExecutivesKey CompetitorsEnvoy MedicalNASDAQ:COCHCollPlant BiotechnologiesNASDAQ:CLGNVicarious SurgicalNYSE:RBOTSanara MedTechNASDAQ:SMTIMilestone ScientificNYSE:MLSSView All CompetitorsInstitutional OwnershipKingswood Wealth Advisors LLCBought 15,300 shares on 4/15/2024Ownership: 0.066%Quadrature Capital LtdBought 16,017 shares on 3/25/2024Ownership: 0.133%PNC Financial Services Group Inc.Bought 7,646 shares on 3/22/2024Ownership: 0.034%Brown Capital Management LLCSold 637,732 shares on 2/15/2024Ownership: 6.694%Kent Lake Capital LLCSold 7,636 shares on 2/14/2024Ownership: 1.954%View All Institutional Transactions INGN Stock Analysis - Frequently Asked Questions Should I buy or sell Inogen stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" INGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INGN, but not buy additional shares or sell existing shares. View INGN analyst ratings or view top-rated stocks. What is Inogen's stock price target for 2024? 4 Wall Street research analysts have issued 12-month target prices for Inogen's shares. Their INGN share price targets range from $7.00 to $8.00. On average, they anticipate the company's stock price to reach $7.50 in the next year. This suggests a possible upside of 11.9% from the stock's current price. View analysts price targets for INGN or view top-rated stocks among Wall Street analysts. How have INGN shares performed in 2024? Inogen's stock was trading at $5.49 at the start of the year. Since then, INGN stock has increased by 22.0% and is now trading at $6.70. View the best growth stocks for 2024 here. Are investors shorting Inogen? Inogen saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,690,000 shares, a drop of 9.6% from the March 15th total of 1,870,000 shares. Based on an average trading volume of 616,700 shares, the short-interest ratio is currently 2.7 days. View Inogen's Short Interest. When is Inogen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our INGN earnings forecast. How can I listen to Inogen's earnings call? Inogen will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13745058". How were Inogen's earnings last quarter? Inogen, Inc. (NASDAQ:INGN) posted its quarterly earnings data on Tuesday, February, 27th. The medical technology company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.65) by $0.49. The medical technology company earned $75.90 million during the quarter, compared to analysts' expectations of $78.09 million. Inogen had a negative net margin of 32.46% and a negative trailing twelve-month return on equity of 38.98%. What ETF holds Inogen's stock? Invesco Nasdaq Future Gen 200 ETF holds 6,173 shares of INGN stock, representing 0.60% of its portfolio. What guidance has Inogen issued on next quarter's earnings? Inogen issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $73.0 million-$74.0 million, compared to the consensus revenue estimate of $80.6 million. What is Scott Wilkinson's approval rating as Inogen's CEO? 70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Inogen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), First Solar (FSLR), Intel (INTC) and Netflix (NFLX). Who are Inogen's major shareholders? Inogen's stock is owned by a variety of retail and institutional investors. Top institutional investors include Kingswood Wealth Advisors LLC (0.07%). Insiders that own company stock include Alison Bauerlein, Brenton Taylor, Holdings A/S Novo, Ray Benjamin M Anderson and Raymond Huggenberger. View institutional ownership trends. How do I buy shares of Inogen? Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INGN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
